BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013;62:124-37. [PMID: 23240674 DOI: 10.1111/his.12048] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 de Almeida BC, Dos Anjos LG, Dobroff AS, Baracat EC, Yang Q, Al-Hendy A, Carvalho KC. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines 2022;10:2567. [PMID: 36289829 DOI: 10.3390/biomedicines10102567] [Reference Citation Analysis]
2 Horn LC, Höhn AK, Denschlag D, Follmann M, Schmidt D. [Interdisciplinary S2k guidelines on the diagnosis and treatment of uterine sarcomas-recommendations for surgical pathology]. Pathologe 2020;41:621-33. [PMID: 32940744 DOI: 10.1007/s00292-020-00826-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Soslow RA, Hameed M. Mesenchymal and Mixed Epithelial–Stromal Malignant Tumors of the Cervix. Atlas of Diagnostic Pathology of the Cervix 2021. [DOI: 10.1007/978-3-030-49954-9_11] [Reference Citation Analysis]
4 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
5 Libertini M, Hallin M, Thway K, Noujaim J, Benson C, van der Graaf W, Jones RL. Gynecological Sarcomas: Molecular Characteristics, Behavior, and Histology-Driven Therapy. Int J Surg Pathol 2021;29:4-20. [PMID: 32909482 DOI: 10.1177/1066896920958120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Shah R, Ervine A. Endometrial Carcinoma. Histopathology Reporting 2020. [DOI: 10.1007/978-3-030-27828-1_24] [Reference Citation Analysis]
7 Shafiee MN, Kah Teik C, Md Zain RR, Kampan N. Ovarian and uterine leiomyosarcoma: which one is the primary? Horm Mol Biol Clin Investig 2019;41. [PMID: 31398145 DOI: 10.1515/hmbci-2019-0037] [Reference Citation Analysis]
8 Saatcioglu HD, Kano M, Horn H, Zhang L, Samore W, Nagykery N, Meinsohn MC, Hyun M, Suliman R, Poulo J, Hsu J, Sacha C, Wang D, Gao G, Lage K, Oliva E, Morris Sabatini ME, Donahoe PK, Pépin D. Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility. Elife 2019;8:e46349. [PMID: 31232694 DOI: 10.7554/eLife.46349] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
9 Tantari M, Barra F, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas. Expert Opinion on Pharmacotherapy 2019;20:713-23. [DOI: 10.1080/14656566.2019.1571042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
10 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
11 Ferreira J, Félix A, Lennerz JK, Oliva E. Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 2018;473:665-78. [DOI: 10.1007/s00428-018-2470-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
12 Baniak N, Adams S, Lee CH, Chibbar R, Kanthan R. Extrapelvic Metastases in Endometrial Stromal Sarcomas: A Clinicopathological Review With Immunohistochemical and Molecular Characterization. Int J Surg Pathol 2019;27:208-15. [PMID: 30124116 DOI: 10.1177/1066896918794278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kefeli M, Caliskan S, Kurtoglu E, Yildiz L, Kokcu A. Leiomyoma With Bizarre Nuclei: Clinical and Pathologic Features of 30 Patients. International Journal of Gynecological Pathology 2018;37:379-87. [DOI: 10.1097/pgp.0000000000000425] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
14 Ho KC, Dean Fang YH, Lin G, Ueng SH, Wu TI, Lai CH, Chueh HY, Chao A, Chang TC, Yen TC. Presurgical Identification of Uterine Smooth Muscle Malignancies through the Characteristic FDG Uptake Pattern on PET Scans. Contrast Media Mol Imaging 2018;2018:7890241. [PMID: 30018513 DOI: 10.1155/2018/7890241] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
15 Kalampokas E, Payne F, Nomikos A, Gurumurthy M. An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology. Gynecol Oncol 2018;150:378-86. [PMID: 29792263 DOI: 10.1016/j.ygyno.2018.05.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
16 Hayashi T, Horiuchi A, Sano K, Hiraoka N, Ichimura T, Sudo T, Ishiko O, Yaegashi N, Aburatani H, Konishi I. Potential Diagnostic Biomarkers: Differential Expression of LMP2/β1i and Cyclin B1 in Human Uterine Leiomyosarcoma. Tumori Journal 2018;100:e99-e106. [DOI: 10.1177/1636.17918] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Hoang L, Chiang S, Lee C. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. Pathology 2018;50:162-77. [DOI: 10.1016/j.pathol.2017.11.086] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 17.0] [Reference Citation Analysis]
18 Zhang R, Gu P, Liu Q, Li B, Bai W. Analysis of diagnosis and treatment of complicated cervical severe adhesion atresia after removal of endometrial stromal nodule: A case report. Medicine (Baltimore) 2017;96:e8979. [PMID: 29310409 DOI: 10.1097/MD.0000000000008979] [Reference Citation Analysis]
19 Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA 3rd, Oliva E, Young RH, Hensley ML, Leitao MM Jr, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol 2018;31:674-84. [PMID: 29192652 DOI: 10.1038/modpathol.2017.162] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 19.4] [Reference Citation Analysis]
20 Hardell E, Josefson S, Ghaderi M, Skeie-jensen T, Westbom-fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW. Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas. American Journal of Surgical Pathology 2017;41:1231-7. [DOI: 10.1097/pas.0000000000000894] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chiang S, Lee CH, Stewart CJR, Oliva E, Hoang LN, Ali RH, Hensley ML, Arias-Stella JA 3rd, Frosina D, Jungbluth AA, Benayed R, Ladanyi M, Hameed M, Wang L, Kao YC, Antonescu CR, Soslow RA. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol 2017;30:1251-61. [PMID: 28621321 DOI: 10.1038/modpathol.2017.42] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 17.6] [Reference Citation Analysis]
22 Alessandrini L, Sopracordevole F, Bertola G, Scalone S, Urbani M, Miolo G, Perin T, Italia F, Canzonieri V. Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literature. Diagn Pathol 2017;12:36. [PMID: 28464838 DOI: 10.1186/s13000-017-0627-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
23 Bennett JA, Sanada S, Selig MK, Hariri LP, Nielsen GP, Oliva E. Giant Cell Tumor of the Uterus: A Report of 3 Cases With a Spectrum of Morphologic Features. Int J Gynecol Pathol 2015;34:340-50. [PMID: 25851705 DOI: 10.1097/PGP.0000000000000164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
24 Roque DR, Taylor KN, Palisoul M, Wysham WZ, Milam B, Robison K, Gehrig PA, Raker C, Kim KH. Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma. Int J Gynecol Cancer 2016;26:505-11. [PMID: 26807641 DOI: 10.1097/IGC.0000000000000634] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
25 Miller H, Ike C, Parma J, Masand RP, Mach CM, Anderson ML. Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma. Sarcoma 2016;2016:7018106. [PMID: 27721667 DOI: 10.1155/2016/7018106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Stewart CJ, Charles A, Foulkes WD. Gynecologic Manifestations of the DICER1 Syndrome. Surgical Pathology Clinics 2016;9:227-41. [DOI: 10.1016/j.path.2016.01.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
27 Hodge JC, Bedroske PP, Pearce KE, Sukov WR. Molecular Cytogenetic Analysis of JAZF1, PHF1, and YWHAE in Endometrial Stromal Tumors: Discovery of Genetic Complexity by Fluorescence in Situ Hybridization. J Mol Diagn 2016;18:516-26. [PMID: 27154512 DOI: 10.1016/j.jmoldx.2016.02.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
28 Uterine Sarcomas. Diagnostic Pathology: Molecular Oncology 2016. [DOI: 10.1016/b978-0-323-37678-5.50175-4] [Reference Citation Analysis]
29 Nucci MR. Practical issues related to uterine pathology: endometrial stromal tumors. Mod Pathol 2016;29:S92-S103. [DOI: 10.1038/modpathol.2015.140] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
30 Oliva E. Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia. Mod Pathol 2016;29:S104-20. [DOI: 10.1038/modpathol.2015.139] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
31 Garcia N, Bozzini N, Baiocchi G, da Cunha IW, Maciel GA, Soares Junior JM, Soares FA, Baracat EC, Carvalho KC. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors? Hum Pathol 2016;50:43-50. [PMID: 26997437 DOI: 10.1016/j.humpath.2015.08.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
32 Conigliaro KM, Kim CH. Update on Uterine Sarcomas. Postgraduate Obstetrics & Gynecology 2015;35:1-5. [DOI: 10.1097/01.pgo.0000472179.70217.f6] [Reference Citation Analysis]
33 Reyes MC, Cooper K. Recently described entities in the gynaecological tract. Pathology 2015;47:414-22. [DOI: 10.1097/pat.0000000000000277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Hensley ML, Barrette BA, Baumann K, Gaffney D, Hamilton AL, Kim JW, Maenpaa JU, Pautier P, Siddiqui NA, Westermann AM, Ray-Coquard I. Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas. Int J Gynecol Cancer 2014;24:S61-6. [PMID: 25341583 DOI: 10.1097/IGC.0000000000000261] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
35 Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015;21:593-615. [PMID: 26141720 DOI: 10.1093/humupd/dmv030] [Cited by in Crossref: 107] [Cited by in F6Publishing: 111] [Article Influence: 15.3] [Reference Citation Analysis]
36 Stewart CJ, Bharat C, Crook M. p16 immunoreactivity in endometrial stromal cells: stromal p16 expression characterises but is not specific for endometrial polyps. Pathology 2015;47:112-7. [DOI: 10.1097/pat.0000000000000211] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
37 Rajanbabu A. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas. Uterine Cancer 2015. [DOI: 10.1007/978-81-322-1892-0_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Soslow RA, Oliva E. Uterine Cancer: Pathology. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_7] [Reference Citation Analysis]
39 Sun X. Female Reproductive System. Well-Differentiated Malignancies 2015. [DOI: 10.1007/978-1-4939-1692-4_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
41 Palacios J, Dal Cin P. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_6] [Reference Citation Analysis]
42 del Carmen MG. Uterine Leiomyosarcoma. Uncommon Gynecologic Cancers 2014. [DOI: 10.1002/9781118655344.ch15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Croce S, Young RH, Oliva E. Uterine leiomyomas with bizarre nuclei: a clinicopathologic study of 59 cases. Am J Surg Pathol 2014;38:1330-9. [PMID: 25140893 DOI: 10.1097/PAS.0000000000000249] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
44 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
45 Kruse A, Croce S, Kruitwagen RF, Riedl RG, Slangen BF, Van Gorp T, Van de Vijver KK. Aggressive Behavior and Poor Prognosis of Endometrial Stromal Sarcomas With YWHAE-FAM22 Rearrangement Indicate the Clinical Importance to Recognize This Subset: . International Journal of Gynecological Cancer 2014;24:1616-22. [DOI: 10.1097/igc.0000000000000278] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
46 Gockley AA, Rauh-hain JA, del Carmen MG. Uterine Leiomyosarcoma: A Review Article. International Journal of Gynecological Cancer 2014;24:1538-42. [DOI: 10.1097/igc.0000000000000290] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
47 Hauptmann S, Köhler G. Etiology, Pathogenesis, and Malignant Potential of Uterine Leiomyoma – A Review. Curr Obstet Gynecol Rep 2014;3:186-90. [DOI: 10.1007/s13669-014-0091-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Zhang Q, Ubago J, Li L, Guo H, Liu Y, Qiang W, Kim JJ, Kong B, Wei JJ. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma. Cancer. 2014;120:3165-3177. [PMID: 24986214 DOI: 10.1002/cncr.28900] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.8] [Reference Citation Analysis]
49 Zhang GF, Zhang H, Tian XM, Zhang H. Magnetic resonance and diffusion-weighted imaging in categorization of uterine sarcomas: correlation with pathological findings. Clin Imaging. 2014;38:836-844. [PMID: 25027800 DOI: 10.1016/j.clinimag.2014.06.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
50 Jin M, Reynolds JP, Odronic SI, Wakely PE. Primary gastric extra-uterine endometrial stromal sarcoma. Annals of Diagnostic Pathology 2014;18:187-90. [DOI: 10.1016/j.anndiagpath.2014.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
51 Stewart CJR, Leung YC, Murch A, Peverall J. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases. Histopathology 2014;65:473-82. [DOI: 10.1111/his.12406] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
52 Linch M, Miah AB, Thway K, Judson IR, Benson C. Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies. Nat Rev Clin Oncol. 2014;11:187-202. [PMID: 24642677 DOI: 10.1038/nrclinonc.2014.26] [Cited by in Crossref: 135] [Cited by in F6Publishing: 147] [Article Influence: 16.9] [Reference Citation Analysis]
53 Schoolmeester JK, Howitt BE, Hirsch MS, Dal Cin P, Quade BJ, Nucci MR. Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic Tract: Clinicopathologic and Immunohistochemical Characterization of 16 Cases. American Journal of Surgical Pathology 2014;38:176-88. [DOI: 10.1097/pas.0000000000000133] [Cited by in Crossref: 118] [Cited by in F6Publishing: 125] [Article Influence: 14.8] [Reference Citation Analysis]
54 Graham JM Jr, Schwartz CE. MED12 related disorders. Am J Med Genet A 2013;161A:2734-40. [PMID: 24123922 DOI: 10.1002/ajmg.a.36183] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
55 Dewaele B, Przybyl J, Quattrone A, Finalet Ferreiro J, Vanspauwen V, Geerdens E, Gianfelici V, Kalender Z, Wozniak A, Moerman P, Sciot R, Croce S, Amant F, Vandenberghe P, Cools J, Debiec‐rychter M. Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma. Int J Cancer 2014;134:1112-22. [DOI: 10.1002/ijc.28440] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 10.6] [Reference Citation Analysis]
56 Allen DC. Endometrial Carcinoma. Histopathology Reporting 2013. [DOI: 10.1007/978-1-4471-5263-7_24] [Reference Citation Analysis]